AIGEN INVESTMENT MANAGEMENT, LP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$555,532
+53.4%
17,569
+69.2%
0.10%
+105.9%
Q4 2022$362,263
-46.0%
10,383
+12.5%
0.05%
-56.0%
Q1 2022$671,000
+64.1%
9,233
+81.3%
0.12%
+114.8%
Q1 2021$409,000
-18.4%
5,093
-44.7%
0.05%
-16.9%
Q4 2020$501,000
-73.4%
9,212
-89.7%
0.06%
-73.1%
Q2 2020$1,883,000
+301.5%
89,571
+133.6%
0.24%
+290.3%
Q1 2020$469,00038,3500.06%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders